Q32 Bio Inc. (LON: 0T6G)
London
· Delayed Price · Currency is GBP · Price in USD 3.418
+0.026 (0.78%)
Jan 22, 2025, 7:15 PM BST
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of 34.02 million as of January 23, 2025.
Market Cap
34.02M
Enterprise Value
-20.36M
Revenue
-10.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.42
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has decreased from 157.73M to 34.02M, a decrease of -78.43%. That is a compound annual growth rate of -84.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 33.62M | 0.44% |
| Dec 31, 2024 | 33.47M | -78.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |